AbbottABT
NYSEPharmaceuticals
No cached AI snapshot yet for ABT.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
115,000 employees1.74B shares outstandingdividend yield 2.69%
Next earnings ~May 5, 2026 · Ex-dividend Apr 15, 2026 · Dividend $0.63 quarterly
About Abbott
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Latest News
Showing market-wide stock news
Here’s Why Polen Focus Growth Exited Abbott Laboratories (ABT) in Q1
Whitbread plc 2026 Q4 - Results - Earnings Call Presentation
JPY Intervention - Unilateral Or Joint Will Be Key
Core inflation rate hit 3.2% in March, as expected; GDP grew 2% in first quarter
Core PCE inflation cools as expected in March
Inflation rate leaps to nearly 3-year high due to Iran war. Now the Fed’s hands are tied.
Related Stocksin Pharmaceuticals
Ready to see the live AI view on ABT?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing ABT side-by-side with live signals.